5 Results for "

GSK2118436

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "GSK2118436" in MCE Product Catalog:

  • Targets Recommended:
83
83 Cited Publications
Cat. No.: HY-14660
CAS No.: 1195765-45-7
Purity:  99.94%
Synonyms: GSK2118436A; GSK2118436
Target:  

Raf CDK

Research Areas:  

Cancer

Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-Raf V600E, respectively .
loading...
    loading...
83
83 Cited Publications
Cat. No.: HY-14660A
CAS No.: 1195768-06-9
Purity:  99.95%
Synonyms: GSK2118436 Mesylate; GSK 2118436B
Target:  

Raf

Research Areas:  

Cancer

Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for Raf V600E and c-Raf, respectively.
loading...
    loading...
Cat. No.: HY-14660R
CAS No.: 1195765-45-7
Synonyms: GSK2118436A (Standard); GSK2118436 (Standard)
Target:  

Reference Standards Raf

Research Areas:  

Cancer

Dabrafenib (Standard) is the analytical standard of Dabrafenib. This product is intended for research and analytical applications. Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-Raf V600E, respectively .
loading...
    loading...
Cat. No.: HY-14660S
CAS No.: 1423119-98-5
Synonyms: GSK2118436A-d9; GSK2118436-d9
Dabrafenib-d9 is the deuterium labeled Dabrafenib. Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively .
loading...
    loading...
Cat. No.: HY-14660AR
CAS No.: 1195768-06-9
Synonyms: GSK2118436 Mesylate (Standard); GSK 2118436B (Standard)
Target:  

Raf Reference Standards

Research Areas:  

Cancer

Dabrafenib (Mesylate) (Standard) is the analytical standard of Dabrafenib (Mesylate). This product is intended for research and analytical applications. Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively.
loading...
    loading...